These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2378786)

  • 1. Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.
    Sesardic D; Boobis AR; Murray BP; Murray S; Segura J; de la Torre R; Davies DS
    Br J Clin Pharmacol; 1990 Jun; 29(6):651-63. PubMed ID: 2378786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression and regulation of members of the cytochrome P450IA gene subfamily in human tissues.
    Sesardic D; Pasanen M; Pelkonen O; Boobis AR
    Carcinogenesis; 1990 Jul; 11(7):1183-8. PubMed ID: 2372876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
    Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
    Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline.
    Kunze KL; Trager WF
    Chem Res Toxicol; 1993; 6(5):649-56. PubMed ID: 8292742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
    Draper AJ; Madan A; Parkinson A
    Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High affinity phenacetin O-deethylase is catalysed specifically by cytochrome P450d (P450IA2) in the liver of the rat.
    Sesardic D; Edwards RJ; Davies DS; Thomas PE; Levin W; Boobis AR
    Biochem Pharmacol; 1990 Feb; 39(3):489-98. PubMed ID: 2306261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a functionally conserved surface region of rat cytochromes P450IA.
    Edwards RJ; Singleton AM; Murray BP; Murray S; Boobis AR; Davies DS
    Biochem J; 1991 Sep; 278 ( Pt 3)(Pt 3):749-57. PubMed ID: 1716884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uroporphyrinogen oxidation catalyzed by reconstituted cytochrome P450IA2.
    Lambrecht RW; Sinclair PR; Gorman N; Sinclair JF
    Arch Biochem Biophys; 1992 May; 294(2):504-10. PubMed ID: 1567206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diazinon is activated by CYP2C19 in human liver.
    Kappers WA; Edwards RJ; Murray S; Boobis AR
    Toxicol Appl Pharmacol; 2001 Nov; 177(1):68-76. PubMed ID: 11708902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.
    Bourrié M; Meunier V; Berger Y; Fabre G
    J Pharmacol Exp Ther; 1996 Apr; 277(1):321-32. PubMed ID: 8613937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotransformation of methylxanthines in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. Allocation of metabolic pathways to isoforms and inhibitory effects of quinolones.
    Fuhr U; Doehmer J; Battula N; Wölfel C; Flick I; Kudla C; Keita Y; Staib AH
    Toxicology; 1993 Oct; 82(1-3):169-89. PubMed ID: 8236273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the inhibition of P4501A2 by furafylline.
    Clarke SE; Ayrton AD; Chenery RJ
    Xenobiotica; 1994 Jun; 24(6):517-26. PubMed ID: 7975717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms.
    Fuhr U; Doehmer J; Battula N; Wölfel C; Kudla C; Keita Y; Staib AH
    Biochem Pharmacol; 1992 Jan; 43(2):225-35. PubMed ID: 1739411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic deactivation of furylfuramide by cytochrome P450 in human and rat liver microsomes.
    Shimada T; Yamazaki H; Shimura H; Tanaka R; Guengerich FP
    Carcinogenesis; 1990 Jan; 11(1):103-10. PubMed ID: 2403855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver.
    Daniel WA; Syrek M; Ryłko Z; Kot M
    Pol J Pharmacol; 2001; 53(6):615-21. PubMed ID: 11985335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19.
    Wienkers LC; Wurden CJ; Storch E; Kunze KL; Rettie AE; Trager WF
    Drug Metab Dispos; 1996 May; 24(5):610-4. PubMed ID: 8723744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
    Heyn H; White RB; Stevens JC
    Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes.
    Campbell ME; Grant DM; Inaba T; Kalow W
    Drug Metab Dispos; 1987; 15(2):237-49. PubMed ID: 2882985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.
    Taavitsainen P; Juvonen R; Pelkonen O
    Drug Metab Dispos; 2001 Mar; 29(3):217-22. PubMed ID: 11181487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct characterization of the selectivity of furafylline as an inhibitor of human cytochromes P450 1A1 and 1A2.
    Tassaneeyakul W; Birkett DJ; Veronese ME; McManus ME; Tukey RH; Miners JO
    Pharmacogenetics; 1994 Oct; 4(5):281-4. PubMed ID: 7894501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.